14 results
8-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
14 Nov 22
Chemomab Announces Appointment of Matthew Frankel, MD, MBA
4:06pm
affairs, along with his outstanding performance in helping to bring biologic and small molecule drugs to market for both rare and chronic diseases
8-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
10 Nov 21
Regulation FD Disclosure
5:06pm
of Fibrosis & Inflammation Across a Wide Range of Models Primary sclerosing cholangitisANIT induced cholestasis-chronic and acute (mice)Bile duct ligation (rat … is a rare, chronic liver disease characterized by progressive course of cholestasis with inflammation and fibrosis of the intrahepatic and extrahepatic
8-K
EX-99.1
91udli8 0019wf
3 Nov 21
Regulation FD Disclosure
4:06pm
8-K
EX-99.1
0utnz372 02zx5s6ysax
25 Oct 21
Regulation FD Disclosure
4:02pm
8-K
EX-99.2
1xaj j47x
2 Sep 21
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief
7:11am
8-K/A
x7ujkn2
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
425
dfq5l4m
9 Mar 21
Business combination disclosure
1:00pm
424B3
t46dwybg9v1buqpv
12 Feb 21
Prospectus supplement
12:05pm
S-4/A
zh85so
10 Feb 21
Registration of securities issued in business combination transactions (amended)
1:19pm
S-4
dpa5337
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
425
7jvg 4f62n
11 Jan 21
Business combination disclosure
10:50am
- Prev
- 1
- Next